Semiconductor diode laser device adjuvanting intradermal vaccine

Yoshifumi Kimizuka, John J. Callahan, Zilong Huang, Kaitlyn Morse, Wataru Katagiri, Ayako Shigeta, Roderick Bronson, Shu Takeuchi, Yusuke Shimaoka, Megan P K Chan, Yang Zeng, Binghao Li, Huabiao Chen, Rhea Y Y Tan, Conor Dwyer, Tyler Mulley, Pierre Leblanc, Calum Goudie, Jeffrey Gelfand, Kosuke TsukadaTimothy Brauns, Mark C. Poznansky, David Bean, Satoshi Kashiwagi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical application. Here we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301 nm light that costs less than $4000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design. This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.

Original languageEnglish
Pages (from-to)2404-2412
Number of pages9
JournalVaccine
Volume35
Issue number18
DOIs
Publication statusPublished - 2017 Apr 25

Fingerprint

semiconductors
Semiconductor Lasers
lasers
Vaccines
vaccines
Lasers
Equipment and Supplies
adjuvants
Solid-State Lasers
vaccination
Vaccination
Mass Vaccination
Technology
Equipment Design
Light
Costs and Cost Analysis
immune response
Semiconductors
dermal exposure
Human Influenza

Keywords

  • Adjuvant
  • Handheld
  • Laser
  • Near-infrared
  • Semiconductor laser diode
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Kimizuka, Y., Callahan, J. J., Huang, Z., Morse, K., Katagiri, W., Shigeta, A., ... Kashiwagi, S. (2017). Semiconductor diode laser device adjuvanting intradermal vaccine. Vaccine, 35(18), 2404-2412. https://doi.org/10.1016/j.vaccine.2017.03.036

Semiconductor diode laser device adjuvanting intradermal vaccine. / Kimizuka, Yoshifumi; Callahan, John J.; Huang, Zilong; Morse, Kaitlyn; Katagiri, Wataru; Shigeta, Ayako; Bronson, Roderick; Takeuchi, Shu; Shimaoka, Yusuke; Chan, Megan P K; Zeng, Yang; Li, Binghao; Chen, Huabiao; Tan, Rhea Y Y; Dwyer, Conor; Mulley, Tyler; Leblanc, Pierre; Goudie, Calum; Gelfand, Jeffrey; Tsukada, Kosuke; Brauns, Timothy; Poznansky, Mark C.; Bean, David; Kashiwagi, Satoshi.

In: Vaccine, Vol. 35, No. 18, 25.04.2017, p. 2404-2412.

Research output: Contribution to journalArticle

Kimizuka, Y, Callahan, JJ, Huang, Z, Morse, K, Katagiri, W, Shigeta, A, Bronson, R, Takeuchi, S, Shimaoka, Y, Chan, MPK, Zeng, Y, Li, B, Chen, H, Tan, RYY, Dwyer, C, Mulley, T, Leblanc, P, Goudie, C, Gelfand, J, Tsukada, K, Brauns, T, Poznansky, MC, Bean, D & Kashiwagi, S 2017, 'Semiconductor diode laser device adjuvanting intradermal vaccine', Vaccine, vol. 35, no. 18, pp. 2404-2412. https://doi.org/10.1016/j.vaccine.2017.03.036
Kimizuka Y, Callahan JJ, Huang Z, Morse K, Katagiri W, Shigeta A et al. Semiconductor diode laser device adjuvanting intradermal vaccine. Vaccine. 2017 Apr 25;35(18):2404-2412. https://doi.org/10.1016/j.vaccine.2017.03.036
Kimizuka, Yoshifumi ; Callahan, John J. ; Huang, Zilong ; Morse, Kaitlyn ; Katagiri, Wataru ; Shigeta, Ayako ; Bronson, Roderick ; Takeuchi, Shu ; Shimaoka, Yusuke ; Chan, Megan P K ; Zeng, Yang ; Li, Binghao ; Chen, Huabiao ; Tan, Rhea Y Y ; Dwyer, Conor ; Mulley, Tyler ; Leblanc, Pierre ; Goudie, Calum ; Gelfand, Jeffrey ; Tsukada, Kosuke ; Brauns, Timothy ; Poznansky, Mark C. ; Bean, David ; Kashiwagi, Satoshi. / Semiconductor diode laser device adjuvanting intradermal vaccine. In: Vaccine. 2017 ; Vol. 35, No. 18. pp. 2404-2412.
@article{2ba525115b794e428b493993e0f154e0,
title = "Semiconductor diode laser device adjuvanting intradermal vaccine",
abstract = "A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical application. Here we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301 nm light that costs less than $4000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design. This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.",
keywords = "Adjuvant, Handheld, Laser, Near-infrared, Semiconductor laser diode, Vaccine",
author = "Yoshifumi Kimizuka and Callahan, {John J.} and Zilong Huang and Kaitlyn Morse and Wataru Katagiri and Ayako Shigeta and Roderick Bronson and Shu Takeuchi and Yusuke Shimaoka and Chan, {Megan P K} and Yang Zeng and Binghao Li and Huabiao Chen and Tan, {Rhea Y Y} and Conor Dwyer and Tyler Mulley and Pierre Leblanc and Calum Goudie and Jeffrey Gelfand and Kosuke Tsukada and Timothy Brauns and Poznansky, {Mark C.} and David Bean and Satoshi Kashiwagi",
year = "2017",
month = "4",
day = "25",
doi = "10.1016/j.vaccine.2017.03.036",
language = "English",
volume = "35",
pages = "2404--2412",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "18",

}

TY - JOUR

T1 - Semiconductor diode laser device adjuvanting intradermal vaccine

AU - Kimizuka, Yoshifumi

AU - Callahan, John J.

AU - Huang, Zilong

AU - Morse, Kaitlyn

AU - Katagiri, Wataru

AU - Shigeta, Ayako

AU - Bronson, Roderick

AU - Takeuchi, Shu

AU - Shimaoka, Yusuke

AU - Chan, Megan P K

AU - Zeng, Yang

AU - Li, Binghao

AU - Chen, Huabiao

AU - Tan, Rhea Y Y

AU - Dwyer, Conor

AU - Mulley, Tyler

AU - Leblanc, Pierre

AU - Goudie, Calum

AU - Gelfand, Jeffrey

AU - Tsukada, Kosuke

AU - Brauns, Timothy

AU - Poznansky, Mark C.

AU - Bean, David

AU - Kashiwagi, Satoshi

PY - 2017/4/25

Y1 - 2017/4/25

N2 - A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical application. Here we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301 nm light that costs less than $4000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design. This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.

AB - A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical application. Here we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301 nm light that costs less than $4000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design. This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.

KW - Adjuvant

KW - Handheld

KW - Laser

KW - Near-infrared

KW - Semiconductor laser diode

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85016565250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016565250&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.03.036

DO - 10.1016/j.vaccine.2017.03.036

M3 - Article

C2 - 28365253

AN - SCOPUS:85016565250

VL - 35

SP - 2404

EP - 2412

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 18

ER -